Author

M. Attias

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Benoit· 1 shared A. Cohen· 1 shared A. Emond· 1 shared A. Galan· 1 shared A. S. Khelifa· 1 shared C. A. Piccirillo· 1 shared C. Chhuon· 1 shared C. Goncalves· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Benoit

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Anti-fungal recombinant psoriasin effectively inhibits Candida albicans growth on denture base

L. A. Lifshits, E. Brohnshtein, M. Attias, Y. Breuer, A. Cohen, M. Gabay, M. Sova, E. Weinberg, E. Zenziper, D. Z. Bar, N. Sterer, M. Gal

This study evaluates psoriasin's ability to inhibit Candida albicans growth on denture bases, finding it effectively eradicates fungal growth when applied to the material.

bioRxiv · Mar 12, 2024Biochemistry

The PP1 phosphatase exhibits pleiotropic roles controlling both the tachyzoite cell cycle and amylopectin-steady state levels in Toxoplasma gondii.

A. S. Khelifa, T. Boissavy, T. Mouveaux, T. Araujo Silva, C. Chhuon, M. Attias, I. C. Guerrera, W. De Souza, D. Dauvillee, E. Roger, M. GISSOT

This study shows that TgPP1 regulates the tachyzoite cell cycle and amylopectin levels in Toxoplasma gondii through post-transcriptional mechanisms.

bioRxiv · Aug 10, 2023Microbiology

The MNK1/2-eIF4E axis contributes to phenotype switching, melanoma progression, and resistance to immunotherapy.

F. Huang, C. Goncalves, M. Bartish, J. Remy-Sarrazin, Q. Guo, A. Emond, W. Yang, D. Plourde, J. Su, M. G. Gimeno, Y. Zhan, M. Attias, A. Galan, T. rzymski, M. Mazan, , S. del Rincon

This study identifies the MNK1/2-eIF4E axis as a driver of melanoma phenotype switching, progression, and immunotherapy resistance, with potential therapeutic targeting.

bioRxiv · May 29, 2020Cancer Biology